Home

Doseerkalkulators

Doseerkalkulators are software tools designed to calculate patient-specific medication dosages or radiopharmaceutical amounts, based on clinical guidelines and pharmacokinetic models, to optimize safety and effectiveness. They are used to translate complex dosing rules into concrete recommendations that account for individual patient characteristics.

They serve a range of purposes in clinical practice, including weight-based dosing, age-based dosing, body surface

Typical inputs include patient weight, height or body surface area, age, sex, renal function (eg, creatinine

Doseerkalkulators are commonly integrated into electronic health record systems, pharmacy software, or available as standalone applications.

Historically, dosing calculations moved from manual calculations and nomograms to computer-assisted systems in the late 20th

area-based
dosing,
and
adjustments
for
renal
or
hepatic
function.
Dosing
intervals,
infusion
rates,
and
combinations
of
drugs
can
also
be
determined,
and
in
some
cases
they
assist
with
dosing
for
vaccines,
contrast
agents,
or
specialized
therapies.
Outputs
typically
include
a
recommended
dose
or
dose
range,
frequency,
and
any
cautions
or
contraindications.
clearance
or
estimated
glomerular
filtration
rate),
hepatic
function,
pregnancy
or
lactation
status,
organ
impairment,
and
drug
properties
such
as
potency,
clearance,
and
interactions.
The
calculators
present
the
user
with
a
suggested
dose,
a
permissible
range,
and
the
dosing
interval,
often
with
notes
on
limitations
and
potential
adjustments.
They
function
as
decision-support
tools
to
aid
clinicians
but
do
not
replace
professional
judgment
or
local
guideline
requirements.
Validation,
regular
updates,
and
awareness
of
guideline
changes
are
essential
to
maintain
accuracy
and
safety.
century,
with
the
rise
of
mobile
and
web-based
calculators
in
the
2000s
and
2010s.
Today,
dose
calculation
tools
are
widely
used
across
pediatrics,
oncology,
nephrology,
and
critical
care
to
support
precise,
evidence-based
dosing.